Comments
Commented by Carsten Mainitz on June 22nd, 2021 | 12:36 CEST
MorphoSys, Defence Therapeutics, Formycon - Biotechnology shares with great potential
In the wake of the corona pandemic, companies such as BioNTech, Pfizer and Moderna demonstrated how quickly and safely vaccines can be developed and mass-produced using innovative biotechnological processes. Biotech stocks have risen in favor again, even outside Covid-19. However, some stocks lag behind the price targets forecast by experts, while others are slowly moving (again) in the right direction. We look at three stocks that offer excellent opportunities at the current price level.
Read
Commented by André Will-Laudien on June 22nd, 2021 | 12:07 CEST
Varta, BYD, NIO, Tesla, Almonty Industries - Battery becomes next billion-dollar topic!
The extent to which reality sometimes diverges from stock market trends is especially noticeable in hotly traded stocks. Early last week, it was the postponement of CureVac's vaccine launch that caused the stock price to lose 50% briefly. Then on Friday, there was the virtual AGM of Varta AG. The mood was very good in the run-up and the share reached a 5-month high of EUR 142. But then there was a correction of over 10% and the price found itself yesterday at EUR 127. The reason: premium manufacturers like Porsche are now going into battery research themselves. This opens up a competitor for Varta among the intended customers - they certainly had not bet on this, but the battery issue is a billion-dollar thing!
Read
Commented by Carsten Mainitz on June 21st, 2021 | 14:19 CEST
Barrick Gold, NSJ Gold, First Majestic Silver- Buy and stay patient
In Gold we trust - is the name of a publication that has been published since 2007 and has become a benchmark for interested gold investors. The authors believe that gold and silver have an excellent chance to climb to higher prices at the end of the current year. For the end of the decade, the experts forecast at least a price of USD 4,800 per ounce of gold. Given such optimistic forecasts, we will look below at three shares that should benefit significantly from this.
Read
Commented by Armin Schulz on June 21st, 2021 | 13:32 CEST
Royal Dutch Shell, Sierra Growth, Nel ASA - Stocks with increased profit opportunities
Since the markets have been climbing incessantly, it is not easy to find exciting stocks with potential. Most of the time, the ratios are already much too high, such as the price-earnings ratio (P/E) or the price-sales ratio (P/S). It is crucial to quickly detect new trends and get in on time before the party is over. In the coming week, an important date is coming up for the large US big tech companies. The House Judiciary Committee will vote on some anti-trust legislation. As a result, tech stocks should be cautious. Today we have picked out three stocks where we think profit opportunities are particularly promising.
Read
Commented by André Will-Laudien on June 21st, 2021 | 12:52 CEST
Porsche, Gazprom, Teck Resources, GSP Resource - The raw materials rally continues!
There was a minor decline on Friday. Rarely could the DAX in recent weeks get caught up in a correction. But on triple witching, it fell from the morning onwards and lost a full 2% to 15,420 points over the course of the day. The all-time high at 15.808 is now a bit removed, and the sidelines also had to give up a bit. The S&P 500 had its first bad week since the significant May correction. However, the chart technicians are still calm; it was probably just a correction in the uptrend. Commodities were largely spared from the correction, Brent and WTI oil at highs near USD 74 and 71 respectively, and copper still just under USD 10,000.
Read
Commented by Nico Popp on June 21st, 2021 | 12:06 CEST
Deutsche Bank, ThyssenKrupp, White Metal Resources: When opportunities arise from legacy issues
What will the market bring in the second half of the year? Will the takeover merry-go-round spin and blue chips continue to climb in the wake of the booming comeback economy? Or do infrastructure programs and further construction drive the steel sector? The chances are good that the economy is again breathing a breath of fresh air and is on the verge of a long-lasting upswing. Traditionally, this upswing is characterized by setbacks, particularly at the beginning. We outline how investors can invest, taking three stocks as examples.
Read
Commented by Nico Popp on June 21st, 2021 | 11:25 CEST
BYD, QMines, Varta: Investors must now think outside the box
E-cars are back! It is not just on the roads that we see more and more electric cars. Shares related to electromobility have also been at the top of the price list again for a few days. After major car manufacturers had already ventured to move toward electromobility months ago, the air was out for some shares. Now, however, the stocks are starting to jump again. In the slipstream of BYD and Co., other shares could pick up. We present some attractive stocks.
Read
Commented by Stefan Feulner on June 21st, 2021 | 10:49 CEST
Palantir, Blackrock Silver, Freenet - Decisive weeks
Uncertainties on the capital markets are increasing, and so is the potential for corrections. The reason is once again the concerns about rampant inflation. After last week's meeting of the US Federal Reserve, key interest rates were left at historic lows, but discussions about curbing bond purchases and possible interest rate hikes as early as 2022 continue to grow. If the FED were to call an end to the ultra-loose monetary policy soon, this would be a fatal sign for the markets with far-reaching consequences.
Read
Commented by Carsten Mainitz on June 18th, 2021 | 15:10 CEST
MorphoSys, Biogen, Sierra Growth - What is next?
Pharmaceutical stocks are a bit like that: Giants like Johnson & Johnson or Novartis have an extensive product portfolio and can cushion failures of individual products quite well. It is often a matter of life and death for smaller, specialized companies with every development. Just yesterday, this could be observed in the CureVac share after its Corona vaccine candidate only achieved an efficacy of 47% in the clinical 2b/3 phase. Within a very short time, it disintegrated the stock price. Meanwhile, biotech pioneer Biogen surprised with an unjustified share price rally, which, however, could come to an abrupt end after a new setback. The situation is different for MorphoSys. Its planned acquisition of Constellation Pharmaceuticals initially weighed heavily on the share price, but it holds exciting potential. And the Canadian mining Company Sierra Growth is operating in a completely different environment; however, it has a top opportunity to offer in the current inflationary environment and should not go unmentioned.
Read
Commented by André Will-Laudien on June 18th, 2021 | 14:39 CEST
Carnival, TUI, Desert Gold - A total upswing or is it all over again?
It is probably one of the strangest travel waves since we could remember. For months we Germans could not leave our own country's borders without great effort; the ski season in 2020/21 fell victim to the COVID pandemic almost completely. Now we experience amazingly low incidences, which probably would have come even without lockdown...but let's take that as a given because some action had to be taken as public proof of action, after all. Now travel is possible again with good conditions for the vaccinated and a bit more cumbersome for recovered, healthy and non-vaccinated. Exciting to observe: How are the travel companies doing now?
Read